Published in Medical Letter on the CDC and FDA, November 11th, 2007
The new trial has a two-stage design. Up to 15 patients with metastatic breast cancer will be enrolled initially and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.